E.M.M.A. International Consulting Group, Inc. Announces New Advisory Board
FARMINGTON HILLS, Mich., Jan. 16, 2020 /PRNewswire-PRWeb/ -- E.M.M.A. International Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting for the Biotechnology, Pharmaceuticals, and Medical Device industries, is pleased to announce new members to their Advisory Board, comprised of representatives from the industry and partner companies with leading expertise in areas relevant to the mission of EMMA International. The Advisory Board will assist EMMA International in expanding and improving its overall business strategy and enhancing marketing and external affairs.
With a wide range of skills and experiences as leaders in their fields, the members of the Advisory Board will work closely with the firm's leadership team to address the growing needs of the market place, and plan for future strategic and regional growth.
The Advisory Board members are:
- Neil Chapman, President, Impact Analytical
- Jan Flegeau, Associate Director of Regulatory Affairs at Johnson & Johnson
- Daniel Medrano, Corporate Vice President at McLaren Health Care
- Fred Molnar, Vice President of Entrepreneur and Innovation at the Michigan Economic Development Corporation (MEDC)
- Stephen T. Rapundalo, PhD, President & CEO of MichBio
"I am delighted to work with such an accomplished group of seasoned professionals. EMMA International is grateful for their support, input and expertise to enable us to keep our finger on the pulse of the industry, said Dr. Carmine Jabri, President of EMMA International. The insight, contribution, and involvement of the Advisory Board will prove to be invaluable to the firm, its leadership team, and all stakeholders involved. The members of the Advisory Board, through their expertise, accomplishments, and astounding reputation, will help EMMA International in its current and future strategic direction."
To learn more about EMMA International's Advisory Board click here.
About EMMA International
EMMA International Consulting Group, Inc. is a global leader in FDA compliance consulting, with headquarters in Farmington Hills, MI. We focus on quality, regulatory, and compliance services for the biotechnology, pharmaceuticals, and medical device industries.
For more information, visit http://www.emmainternational.com/.
If you would like additional information, please contact Kira Jabri, CEO at 248-987-4497 or email at email@example.com.
SOURCE EMMA International
Inside Fonds (Anzeige)
SMI geht im Plus ins Wochenende -- DAX schliesst stärker -- Dow beendet Handel im Minus -- Asiens Börsen letztlich knapp im Plus
Börse aktuell - Live Ticker
Am heimischen Markt ging es vor dem Wochenende noch einmal aufwärts. Auch der DAX bewegte sich in der Gewinnzone. Der Dow zeigte sich unentschlossen. Die Aktienmärkte in Fernost tendierten am Freitag etwas höher.